Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studies.
about
Medical and Surgical Treatment of Hidradenitis Suppurativa: A Review.Association Between Inflammatory Skin Disease and Cardiovascular and Cerebrovascular Co-Morbidities in US Adults: Analysis of Nationwide Inpatient Sample Data.Hidradenitis Suppurativa and electrocardiographic changes - a cross-sectional population study.Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder?Adalimumab: A Review in Hidradenitis Suppurativa.Development and validation of IHS4, a novel dynamic scoring system to assess hidradenitis suppurativa/acne inversa severity.Assessment of subclinical atherosclerosis in hidradenitis suppurativa.MMP8 Is Increased in Lesions and Blood of Acne Inversa Patients: A Potential Link to Skin Destruction and Metabolic Alterations.Cardiovascular disease risk factors in patients with hidradenitis suppurativa.Carotid ultrasound is useful for the cardiovascular risk stratification in patients with hidradenitis suppurativa.Recommendations for the management of comorbidity in hidradenitis suppurativa.Can positron emission tomography (PET) unravel the link between adipose tissue, vascular inflammation and cardiovascular risk in patients with psoriasis?Pharmaceutical Benefits Scheme listing of adalimumab for hidradenitis suppurativa: Is hidradenitis suppurativa a life-changing drug or does lifestyle change the drug?Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients.Increased total serum IgE levels in moderate-to-severe hidradenitis suppurativa.Framingham risk assessment in hidradenitis suppurativa.Hidradenitis suppurativa is not associated with the metabolic syndrome based on body type: A cross-sectional study.
P2860
Q30234313-E697EA7B-D8CA-4611-9B13-80E8ED8164D9Q36378437-C3E7B32A-8AC7-4DCD-B756-C5900F6C46A7Q38698982-124FE8AE-DF17-4A12-A92D-3ED7E4A7F0C9Q38863293-A0C72B3A-66B6-45DF-B66A-ED709A0500CCQ38963759-873D39EF-FC34-47CB-BDF3-1E814EEE92DAQ40163694-23771FE2-D5BE-4218-B561-959BF55DDD07Q40445004-B5FF8B97-FD9F-426E-85EE-EB09459E7C97Q40452424-58724FB4-A0F3-4DBA-B964-8442401E658FQ40832450-88C0C1E6-B0FB-4879-87B5-517E607CCE7AQ47557825-AEF67CBC-960A-4342-B35D-5477D279620FQ47801282-997CDEA6-2C17-47B6-B1F6-2C1F211984C5Q48266352-5168E3F7-E06D-410E-886E-018EEAC57553Q48333995-786A3286-F5F2-4047-AB21-E12FBBAD3D1FQ50350856-30DC04FB-B345-455C-B52B-5484F5C54E40Q51636223-02ED227F-4840-4B94-872D-9B7119538A8AQ53122374-30C9655D-ABBD-4420-B50E-1C473EB730EFQ54526379-50F5B7A8-3CAF-47DE-A4A8-002D3BCDDF74
P2860
Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studies.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cardiovascular disease risk fa ...... ysis of observational studies.
@en
type
label
Cardiovascular disease risk fa ...... ysis of observational studies.
@en
prefLabel
Cardiovascular disease risk fa ...... ysis of observational studies.
@en
P2093
P2860
P356
P1476
Cardiovascular disease risk fa ...... lysis of observational studies
@en
P2093
C C Zouboulis
W Gulliver
P2860
P304
P356
10.1111/BJD.14024
P407
P577
2015-09-22T00:00:00Z